81 related articles for article (PubMed ID: 15781251)
1. Histone deacetylase inhibitor Trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription.
Lu ZP; Ju ZL; Shi GY; Zhang JW; Sun J
Biochem Biophys Res Commun; 2005 Apr; 330(1):204-9. PubMed ID: 15781251
[TBL] [Abstract][Full Text] [Related]
2. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
7. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
8. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
Gao J; Chen T; Liu J; Liu W; Hu G; Guo X; Yin B; Gong Y; Zhao J; Qiang B; Yuan J; Peng X
Glia; 2009 Jul; 57(9):989-99. PubMed ID: 19062177
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
Choi YH
Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 3 represses HTLV-1 tax transcription.
Villanueva R; Iglesias AH; Camelo S; Sanin LC; Gray SG; Dangond F
Oncol Rep; 2006 Sep; 16(3):581-5. PubMed ID: 16865259
[TBL] [Abstract][Full Text] [Related]
11. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
Han SB; Lee JK
Arch Pharm Res; 2009 Apr; 32(4):613-24. PubMed ID: 19407980
[TBL] [Abstract][Full Text] [Related]
13. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
15. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
Sng JC; Taniura H; Yoneda Y
Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
[TBL] [Abstract][Full Text] [Related]
18. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
Hernandez M; Shao Q; Yang XJ; Luh SP; Kandouz M; Batist G; Laird DW; Alaoui-Jamali MA
Prostate; 2006 Aug; 66(11):1151-61. PubMed ID: 16652385
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina.
Wallace DM; Cotter TG
J Neurosci Res; 2009 Mar; 87(4):887-905. PubMed ID: 18951482
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
Reilly CM; Thomas M; Gogal R; Olgun S; Santo A; Sodhi R; Samy ET; Peng SL; Gilkeson GS; Mishra N
J Autoimmun; 2008 Sep; 31(2):123-30. PubMed ID: 18650065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
